Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EARNINGS: Ebiquity swings to profit; SDX Energy swings to loss

29th Sep 2023 11:51

(Alliance News) - The following is a round-up of earning and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Ebiquity PLC - London-based media and marketing consultancy - Swings to pretax profit in the first half of 2023 of GBP1.4 million, from a loss of GBP1.4 million a year prior. Revenue climbs 11% to GBP40.6 million from GBP36.7 million. Declares no dividend, unchanged. On the company's outlook, Chief Executive Officer Nick Waters says: "While we are seeing some major customers cutting budgets as a result of prevailing market conditions and trends, Ebiquity continues to trade broadly in line with expectations. Looking further ahead, as the market leader we remain well positioned to help our clients and see further opportunities for revenue growth and margin enhancement."

----------

Hydrogen Utopia International PLC - London-based operator of facilities that turn non-recyclable mixed waste plastic into hydrogen and other carbon-free fuels, new materials, or distributed renewable heat - In the first half of 2023, pretax loss widens to GBP766,836 from GBP583,874 a year prior. Posts no revenue in either half-year. Says outlook remains "very" positive, cites high degree of confidence in executing strategy.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - In the financial year to March 31, pretax loss widens to GBP419,916 from GBP299,132 a year prior. Revenue falls to GBP389,916 from GBP426,168. Cost of goods sold increases to GBP95,497 from GBP46,119. Looking ahead, Chair Dawson Buck and CEO Ian Ford say board is "strongly positive about the outlook for Fruitflow and the Provexis business for the coming year and beyond."

----------

RegTech Open Project PLC - technology business focused on automation and optimisation of regulatory compliance operations - Announces results for period from March 10 to June 30. Reports GBP50,000 worth of assets as at June 30. Notes 50% annual growth on invoiced basis to GBP588,000 in the first half of 2023 from GBP391,000 a year prior. Reports no profit or loss, revenue, or costs. Company listed on the main market of the London Stock exchange on August 25. Confirms that Paul McFadden will be chief financial officer from December 5. Further, enters into side letter agreement cast as a deed, with RegTech Open Project SpA, ultimately owned by RegTech Open Project PLC founder Alessandro Zamboni. Notes that since completion of direct listing, a total of GBP2.5 million funds have been drawn under English law.

----------

SDX Energy PLC - London-based energy company, with portfolio of exploration, development and production assets in Egypt and Morocco - Swings to pretax loss in the six months to June 30, of USD397,000, from a profit of USD1.9 million a year prior. Revenue net of royalties falls 32% to USD15.3 million from USD22.3 million. Direct operating expense increases 17% to USD5.1 million from USD4.4 million. Looking ahead, cites planned workover of Egypt-based Rabul Deep-1 well, to convert it to a water-injector for the Rabul field.

----------

TechFinancials Inc - purely investment entity since 2022 after closing operating entities in Israel - Pretax loss in the first half of 2023 narrows to USD73,000 from USD163,000 a year prior. Posts no revenue in either half-year. Looking ahead, Chair Eitan Yanuv says: "We will continue to look for opportunities to materialize our assets or join forces with other companies in order to be able move forward."

----------

Verici Dx PLC - Cardiff, Wales-based developer of clinical diagnostics for organ transplants - Pretax loss in the first half of 2023 narrows to USD5.3 million from USD5.5 million prior. Reports USD19,000 revenue compared to none a year ago. Looking ahead, Verici is focused on speeding up the commercial roll-out of Tutivia, Chief Executive Sara Barrington says. Tutivia is a single test that uses RNA signature technology to assist in improving a patient's personalised post-kidney transplant care.

----------

By Tom Budszus, Alliance News reporter

Comments and questions to [email protected]

Copyright 2023 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value8,139.83
Change60.97